22 May 2013
Keywords: roche, xeloda, cleared, first-line, colorectal, cancer, therapy
Article | 02 May 2001
Roche's orally-active anticancer drug Xeloda (capecitabine) has beenapproved by the US Food and Drug Administration for the first-line
treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 May 2001
3 May 2001
21 May 2013
© 2013 thepharmaletter.com